Theragenics (TGX) Stock Price, News & Analysis

Company Overview

Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufactures, assembles, packages and distributes its surgical products in three primary production facilities, each of which manufactures different products. In October 2013, the Company announced that it has completed the merger with Juniper Acquisition Corporation.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 2,160 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TGX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Theragenics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Theragenics investors own include Capri (CPRI), Chewy (CHWY), Aphria (APHA), Citi Trends (CTRN), Dillard's (DDS), DocuSign (DOCU) and Diamondback Energy (FANG).

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NYSE:TGX
• CIK: 795551
• Web: www.theragenics.com
• Phone: +1-770-8315137
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A